Lessee, Operating Lease, Liability, to be Paid of VBI Vaccines Inc/BC from 30 Sep 2019 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
VBI Vaccines Inc/BC quarterly Lessee, Operating Lease, Liability, to be Paid in USD history and change rate from 30 Sep 2019 to 31 Mar 2024.
  • VBI Vaccines Inc/BC Lessee, Operating Lease, Liability, to be Paid for the quarter ending 31 Mar 2024 was $2,243,000, a 38% decline year-over-year.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Change (%)

VBI Vaccines Inc/BC Quarterly Lessee, Operating Lease, Liability, to be Paid (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $2,243,000 -$1,363,000 -38% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 $2,619,000 -$1,442,000 -36% 31 Dec 2023 10-K 16 Apr 2024 2023 FY
Q3 2023 $2,824,000 -$1,479,000 -34% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $3,222,000 -$984,000 -23% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $3,606,000 -$1,242,000 -26% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $4,061,000 -$131,000 -3.1% 31 Dec 2022 10-K 13 Mar 2023 2022 FY
Q3 2022 $4,303,000 +$3,785,000 +731% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $4,206,000 +$3,010,000 +252% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $4,848,000 +$3,398,000 +234% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $4,192,000 +$2,486,000 +146% 31 Dec 2021 10-K 07 Mar 2022 2021 FY
Q3 2021 $518,000 -$1,307,000 -72% 30 Sep 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 $1,196,000 -$865,000 -42% 30 Jun 2021 10-Q 02 Aug 2021 2021 Q2
Q1 2021 $1,450,000 +$101,000 +7.5% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $1,706,000 +$68,000 +4.2% 31 Dec 2020 10-K 02 Mar 2021 2020 FY
Q3 2020 $1,825,000 -$28,000 -1.5% 30 Sep 2020 10-Q 02 Nov 2020 2020 Q3
Q2 2020 $2,061,000 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 $1,349,000 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 $1,638,000 31 Dec 2019 10-K 05 Mar 2020 2019 FY
Q3 2019 $1,853,000 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.